Delivery Order SPE2DR25D2012-SPE2DR26F1BSQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,228.81 to AmerisourceBergen Drug Corp for ACT-O-VIALS on December 17, 2025, with an ultimate completion date of December 18, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,425.07 to AmerisourceBergen Drug Corp for ACT-O-VIALS on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a $1,992.15 delivery order to AmerisourceBergen Drug Corp for ACT-O-Vials on December 10, 2025, with an ultimate completion date of December 11, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $4,470.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for ACT-O-VIALS with an ultimate completion date of December 15, 2025. This non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at the contractor's Corporate Office location in...
- The Defense Logistics Agency awarded a delivery order valued at $10,604.05 to AmerisourceBergen Drug Corp on December 11, 2025, for ACT-O-VIALS pharmaceutical products. The contract represents a firm fixed price delivery order with an ultimate completion date of December 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract and was competitively awarded through open competition. This...
- The Defense Logistics Agency awarded a delivery order valued at $6,813.71 to AmerisourceBergen Drug Corp for ACT-O-VIALS, effective January 5, 2026, with completion by January 6, 2026. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order is being fulfilled from the contractor's...
- The Defense Logistics Agency awarded a $1,425.07 delivery order (Contract No. 4570442708) to AmerisourceBergen Drug Corp for ACT-O-VIALS on January 8, 2026, with an ultimate completion date of January 9, 2026. This firm fixed-price delivery order represents a non-set-aside award issued competitively to the prime contractor, with performance occurring at the company's Conshohocken, Pennsylvania location. The award falls under AmerisourceBergen's parent company, Cencora, Inc., which holds a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,968.60 firm fixed-price delivery order for ACT-O-VIALS with an ultimate completion date of December 22, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken,...
- On January 7, 2026, the Defense Logistics Agency awarded a delivery order valued at $7,873.30 to Amerisourcebergen Drug Corp for Act-O-Vials pharmaceutical supplies. This firm fixed-price delivery order, which carries a completion date of February 4, 2026, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is issued without set-aside designation, indicating competitive selection among qualified vendors. Amerisourcebergen Drug Corp, a...
- The Defense Logistics Agency awarded a delivery order valued at $12,213.84 to AmerisourceBergen Drug Corp for ACT-O-VIALS on December 16, 2025, with an ultimate completion date of December 17, 2025. This firm fixed-price, non-set-aside contract is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- SPE2DR25D2012Indefinite Delivery Contract
- SPE2DR25D2012-SPE2DR26F1BSQDelivery Order
On January 13, 2026, the Defense Logistics Agency awarded a delivery order valued at $1,425.07 to AmerisourceBergen Drug Corp for ACT-O-VIALS, with an ultimate completion date of January 14, 2026. This is a firm fixed-price delivery order issued under a competitive process with no set-aside designation. The awardee, AmerisourceBergen Drug Corp, is headquartered in Conshohocken, Pennsylvania, and serves as a critical pharmaceutical distributor to federal medical procurement programs, particularly for military and veteran healthcare systems. The parent company is Cencora, Inc., which does business as AmerisourceBergen. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. That prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits to support military healthcare programs worldwide. The delivery order supports federal medical supply needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 1/12/26 |